Neurosurgery

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
bookPart
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER INTERNATIONAL PUBLISHING
Citação
Lepski, G. A.; Nepomuceno, T. B.. Neurosurgery. In: . Vascular Surgery in Oncology: SPRINGER INTERNATIONAL PUBLISHING, 2022. p.311-329.
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The oncological treatment of intracranial tumors demands an experienced and multidisciplinary team able to manage vascular complications and perform reconstructive procedures when needed. Some brain tumors dislocate, enclose, and sometimes invade major arterial and venous structures of the brain, which if sacrificed may lead to unacceptable neurological deficits. Since the brain tumor treatment is a balance between preserving function and removing the greatest amount of tumor possible, the oncological neurosurgeon must also be trained to perform arterial and venous reconstruction and bypasses. In the present chapter, we address reconstructive strategies in the arterial and venous systems to preserve brain hemodynamics, either in the elective or emergent conditions. Brain tumors increase the risk of venous thromboembolism, which complicates the decision as to when to start anticoagulation (either before or after brain surgery). In addition, postoperative bleeding is a major complication, potentially culminating in death or serious neurological deficits. Nevertheless, many studies have demonstrated that thromboembolism risk overcomes the risk of postoperative bleeding in the neurosurgical oncology cohort, so that most protocols recommend early prophylaxis. This does not preclude the need for multifactorial and individual-based decision-making, paying careful attention to patient- and surgery-related risks. © Springer Nature Switzerland AG 2022.
Palavras-chave
Anticoagulation after brain surgery, Brain tumors, Carotid injury, Glioma, Intracranial bypass surgery, Meningioma, Transsphenoidal approach, Venous sinus reconstruction
Referências
  1. Ostrom Q.T., Wright C.H., Barnholtz-Sloan J.S., Brain metastases: Epidemiology, Handb Clin Neurol, 149, pp. 27-42, (2018)
  2. DeMonte F., McDermott M.W., Al-Mefty O., Al-Mefty’s meningiomas, (2011)
  3. Ostrom Q.T., Cioffi G., Gittleman H., Et al., CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016, Neuro Oncol, 21, pp. v1-v100, (2019)
  4. Osorio J.A., Benet A., Hess C.P., McDermott M.W., Abla A.A., Primary vertebral artery reanastomosis during retrosigmoid skull base approach following iatrogenic near-transection with monopolar electrocautery, Neurosurgery, 10, pp. 631-639, (2014)
  5. Rangel-Castilla L., McDougall C.G., Spetzler R.F., Nakaji P., Urgent cerebral revascularization bypass surgery for iatrogenic skull base internal carotid artery injury, Neurosurgery, 10, pp. 640-647, (2014)
  6. Raymond J., Hardy J., Czepko R., Roy D., Arterial injuries in transsphenoidal surgery for pituitary adenoma
  7. the role of angiography and endovascular treatment, AJNR Am J Neuroradiol, 18, pp. 655-665, (1997)
  8. Cinar C., Bozkaya H., Parildar M., Oran I., Endovascular management of vascular injury during transsphenoidal surgery, Interv Neuroradiol, 19, pp. 102-109, (2013)
  9. Ahuja A., Guterman L.R., Hopkins L.N., Carotid cavernous fistula and false aneurysm of the cavernous carotid artery: Complications of transsphenoidal surgery, Neurosurgery, 31, pp. 774-778, (1992)
  10. Yamaura A., Makino H., Hachisu H., Takemiya S., Secondary aneurysm due to arterial injury during surgical procedures, Surg Neurol, 10, pp. 327-333, (1978)
  11. Gardner P.A., Tormenti M.J., Pant H., Fernandez-Miranda J.C., Snyderman C.H., Horowitz M.B., Carotid artery injury during endoscopic endonasal skull base surgery: Incidence and outcomes, Neurosurgery, 73, pp. 261-269, (2013)
  12. Sutton L.N., Vascular complications of surgery for craniopharyngioma and hypothalamic glioma, Pediatr Neurosurg, 21, pp. 124-128, (1994)
  13. Aydin E., Gok M., Esenkaya A., Cinar C., Oran I., Endovascular management of Iatrogenic vascular injury in the craniocervical region, Turk Neurosurg, 28, pp. 72-78, (2018)
  14. McCracken D.J., Higginbotham R.A., Boulter J.H., Et al., Degree of vascular encasement in sphenoid wing meningiomas predicts postoperative ischemic complications, Neurosurgery, 80, pp. 957-966, (2017)
  15. Micko A.S.G., Wohrer A., Wolfsberger S., Knosp E., Invasion of the cavernous sinus space in pituitary adenomas: Endoscopic verification and its correlation with an MRI-based classification, J Neurosurg, 122, pp. 803-811, (2015)
  16. Champagne P.O., Lemoine E., Bojanowski M.W., Surgical management of giant sphenoid wing meningiomas encasing major cerebral arteries, Neurosurg Focus, 44, (2018)
  17. Kotapka M.J., Kalia K.K., Martinez A.J., Sekhar L.N., Infiltration of the carotid artery by cavernous sinus meningioma, J Neurosurg, 81, pp. 252-255, (1994)
  18. Goldbrunner R., Minniti G., Preusser M., Et al., EANO guidelines for the diagnosis and treatment of meningiomas, Lancet Oncol, 17, pp. e383-e391, (2016)
  19. Weller M., van den Bent M., Tonn J.C., Et al., European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas, Lancet Oncol, 18, pp. e315-e329, (2017)
  20. Winn H.R., Youmans J.R., Youmans and Winn neurological surgery, (2017)
  21. Queiroz M.A., Barbosa F.G., Buchpiguel C.A., Cerri G.G., Positron emission tomography/magnetic resonance imaging (PET/MRI): An update and initial experience at HC-FMUSP, Rev Assoc Med Bras, 64, pp. 71-84, (2018)
  22. Vajkoczy P., Revival of extra-intracranial bypass surgery, Curr Opin Neurol, 22, pp. 90-95, (2009)
  23. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial, N Engl J Med, 313, pp. 1191-1200, (1985)
  24. Powers W.J., Clarke W.R., Grubb R.L., Videen T.O., Adams H.P., Derdeyn C.P., Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: The Carotid Occlusion Surgery Study randomized trial, JAMA, 306, pp. 1983-1992, (2011)
  25. Yang T., Tariq F., Chabot J., Madhok R., Sekhar L.N., Cerebral revascularization for difficult skull base tumors: A contemporary series of 18 patients, World Neurosurg, 82, pp. 660-671, (2014)
  26. Thines L., Proust F., Marinho P., Et al., Giant and complex aneurysms treatment with preservation of flow via bypass technique, Neurochirurgie, 62, pp. 1-13, (2016)
  27. Abdulrauf S.I., Sweeney J.M., Mohan Y.S., Palejwala S.K., Short segment internal maxillary artery to middle cerebral artery bypass: A novel technique for extracranial-to-intracranial bypass, Neurosurgery, 68, pp. 804-808, (2011)
  28. Bulsara K.R., Patel T., Fukushima T., Cerebral bypass surgery for skull base lesions: Technical notes incorporating lessons learned over two decades, Neurosurg Focus, 24, (2008)
  29. Lawton M.T., Hamilton M.G., Morcos J.J., Spetzler R.F., Revascularization and aneurysm surgery:Current techniques, indications, and outcome, Neurosurgery, 38, pp. 83-92, (1996)
  30. Sekhar L.N., Kalavakonda C., Cerebral revascularization for aneurysms and tumors, Neurosurgery, 50, pp. 321-331, (2002)
  31. Tulleken C.A., Verdaasdonk R.M., Berendsen W., Mali W.P., Use of the excimer laser in high-flow bypass surgery of the brain, J Neurosurg, 78, pp. 477-480, (1993)
  32. Hendrikse J., van der Zwan A., Ramos L.M., Tulleken C.A., van der Grond J., Hemodynamic compensation via an excimer laser-assisted, high-flow bypass before and after therapeutic occlusion of the internal carotid artery, Neurosurgery, 53, pp. 858-863, (2003)
  33. van der Zwan A., Vajkoczy P., Amin-Hanjani S., Et al., Final results of the prospective multicenter excimer laser-assisted high-flow bypass study on the treatment of giant anterior circulation aneurysms, Neurosurgery, 87, pp. 697-703, (2020)
  34. Mazur M.D., Cutler A., Couldwell W.T., Taussky P., Management of meningiomas involving the transverse or sigmoid sinus, Neurosurg Focus, 35, (2013)
  35. Sindou M., Meningiomas invading the sagittal or transverse sinuses, resection with venous reconstruction, J Clin Neurosci, 8, pp. 8-11, (2001)
  36. Zeeshan Q., Patel A., Cheng C.Y., Et al., Resection of meningiomas involving major dural venous sinuses: Classification, technique, and long-term results, World Neurosurg, 125, pp. e521-e536, (2019)
  37. Wolfswinkel E.M., Landau M.J., Ravina K., Kokot N.C., Russin J.J., Carey J.N., EC-IC bypass for cerebral revascularization following skull base tumor resection: Current practices and innovations, J Surg Oncol, 118, pp. 815-825, (2018)
  38. Sekhar L.N., Natarajan S.K., Ellenbogen R.G., Ghodke B., Cerebral revascularization for ischemia, aneurysms, and cranial base tumors, Neurosurgery, 62, pp. 1373-1408, (2008)
  39. Carrabba G., Riva M., Conte V., Et al., Risk of post-operative venous thromboembolism in patients with meningioma, J Neurooncol, 138, pp. 401-406, (2018)
  40. Lin R.J., Green D.L., Shah G.L., Therapeutic anticoagulation in patients with primary brain tumors or secondary brain metastasis, Oncologist, 23, pp. 468-473, (2018)
  41. Jo J.T., Schiff D., Perry J.R., Thrombosis in brain tumors, Semin Thromb Hemost, 40, pp. 325-331, (2014)
  42. Yust-Katz S., Mandel J.J., Wu J., Et al., Venous thromboembolism (VTE) and glioblastoma, J Neurooncol, 124, pp. 87-94, (2015)
  43. Zwicker J.I., Karp Leaf R., Carrier M., A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation, J Thromb Haemost, 14, pp. 1736-1740, (2016)
  44. Mantia C., Uhlmann E.J., Puligandla M., Weber G.M., Neuberg D., Zwicker J.I., Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin, Blood, 129, pp. 3379-3385, (2017)
  45. Carrier M., Khorana A.A., Zwicker J., Et al., Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: Guidance from the SSC of the ISTH, J Thromb Haemost, 11, pp. 1760-1765, (2013)
  46. Shaikhouni A., Baum J., Lonser R.R., Deep vein thrombosis prophylaxis in the neurosurgical patient, Neurosurg Clin N Am, 29, pp. 567-574, (2018)
  47. Anderson D.R., Morgano G.P., Bennett C., Et al., American Society of Hematology 2019 guidelines for management of venous thromboembolism: Prevention of venous thromboembolism in surgical hospitalized patients, Blood Adv, 3, pp. 3898-3944, (2019)
  48. Faraoni D., Comes R.F., Geerts W., Wiles M.D., European guidelines on perioperative venous thromboembolism prophylaxis: Neurosurgery, Eur J Anaesthesiol, 35, pp. 90-95, (2018)
  49. Cote L.P., Greenberg S., Caprini J.A., Et al., Outcomes in neurosurgical patients who develop venous thromboembolism: A review of the RIETE registry, Clin Appl Thromb Hemost, 20, pp. 772-778, (2014)
  50. Scheller C., Rachinger J., Strauss C., Alfieri A., Prell J., Koman G., Therapeutic anticoagulation after craniotomies: Is the risk for secondary hemorrhage overestimated?, J Neurol Surg A Cent Eur Neurosurg, 75, pp. 2-6, (2014)
  51. Wolpert F., Berghoff A.S., Grossenbacher B., Et al., Venous thromboembolic events in patients with brain metastases: The PICOS score, Eur J Cancer, 134, pp. 75-85, (2020)
  52. Knosp E., Steiner E., Kitz K., Matula C., Pituitary adenomas with invasion of the cavernous sinus space: A magnetic resonance imaging classification compared with surgical findings, Neurosurgery, 33, 4, pp. 610-617, (1993)
  53. Key N.S., Khorana A.A., Kuderer N.M., Bohlke K., Lee A.Y.Y., Arcelus J.I., Wong S.L., Balaban E.P., Flowers C.R., Francis C.W., Gates L.E., Kakkar A.K., Levine M.N., Liebman H.A., Tempero M.A., Lyman G.H., Falanga A., Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update, J Clin Oncol, 38, 5, pp. 496-520, (2020)
  54. Khorana A.A., Noble S., Lee A.Y.Y., Soff G., Meyer G., O'Connell C., Carrier M., Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: Guidance from the SSC of the ISTH, J Thromb Haemost, 16, 9, pp. 1891-1894, (2018)
  55. Perry J.R., Julian J.A., Laperriere N.J., Et al., PRODIGE: A randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma, J Thromb Haemost, 8, pp. 1959-1965, (2010)
  56. Ruff R.L., Posner J.B., Incidence and treatment of peripheral venous thrombosis in patients with glioma, Ann Neurol, 13, pp. 334-336, (1983)
  57. Wakai S., Yamakawa K., Manaka S., Takakura K., Spontaneous intracranial hemorrhage caused by brain tumor: Its incidence and clinical significance, Neurosurgery, 10, pp. 437-444, (1982)
  58. Chinot O.L., Wick W., Mason W., Et al., Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma, N Engl J Med, 370, pp. 709-722, (2014)
  59. Mandybur T.I., Intracranial hemorrhage caused by metastatic tumors, Neurology, 27, pp. 650-655, (1977)
  60. Nghiemphu P.L., Green R.M., Pope W.B., Et al., Safety of anticoagulation use and bevacizumab in patients with glioma, Neuro Oncol, 10, pp. 355-360, (2008)
  61. Norden A.D., Bartolomeo J., Tanaka S., Et al., Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients, J Neurooncol, 106, pp. 121-125, (2012)
  62. Teivelis M.P., Schettini I.H., Pignataro B.S., Zottele Bomfim G.A., Centofanti G., Fonseca I.Y.I., Krutman M., Cavalcante R.N., Nishinari K., Yazbek G., Inferior vena cava filter in cancer patients: On whom should we be placing them?, Ann Vasc Surg, 71, pp. 220-229, (2021)
  63. Leiderman D.B.D., Zerati A.E., Vieira Mariz M.P., Wolosker N., Puech-Leao P., De Luccia N., The need for a vena cava filter in oncological patients with acute venous thrombosis: A marker of a worse prognosis, Ann Vasc Surg, 60, pp. 35-44, (2019)
  64. Lee A.Y., Levine M.N., Baker R.I., Et al., Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer, N Engl J Med, 349, pp. 146-153, (2003)
  65. Raskob G.E., van Es N., Verhamme P., Et al., Edoxaban for the treatment of cancer-associated venous thromboembolism, N Engl J Med, 378, pp. 615-624, (2018)
  66. Young A.M., Marshall A., Thirlwall J., Et al., Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: Results of a randomized trial (SELECT-D), J Clin Oncol, 36, pp. 2017-2023, (2018)
  67. McBane R.D., Wysokinski W.E., Le-Rademacher J.G., Et al., Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial, J Thromb Haemost, 18, pp. 411-421, (2020)
  68. Agnelli G., Becattini C., Bauersachs R., Et al., Apixaban versus dalteparin for the treatment of acute venous thromboembolism in patients with cancer: The Caravaggio study, Thromb Haemost, 118, pp. 1668-1678, (2018)
  69. Semrad T.J., O'Donnell R., Wun T., Et al., Epidemiology of venous thromboembolism in 9489 patients with malignant glioma, J Neurosurg, 106, pp. 601-608, (2007)
  70. Chan A.T., Atiemo A., Diran L.K., Et al., Venous thromboembolism occurs frequently in patients undergoing brain tumor surgery despite prophylaxis, J Thromb Thrombolysis, 8, pp. 139-142, (1999)
  71. Smith T.R., Lall R.R., Graham R.B., Et al., Venous thromboembolism in high grade glioma among surgical patients: Results from a single center over a 10 year period, J Neuro-Oncol, 120, pp. 347-352, (2014)
  72. Agnelli G., Piovella F., Buoncristiani P., Et al., Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery, N Engl J Med, 339, pp. 80-85, (1998)
  73. Iorio A., Agnelli G., Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: A meta-analysis, Arch Intern Med, 160, pp. 2327-2332, (2000)
  74. Constantini S., Kanner A., Friedman A., Et al., Safety of perioperative minidose heparin in patients undergoing brain tumor surgery: A prospective, randomized, double-blind study, J Neurosurg, 94, pp. 918-921, (2001)
  75. Alshehri N., Cote D.J., Hulou M.M., Et al., Venous thromboembolism prophylaxis in brain tumor patients undergoing craniotomy: A meta-analysis, J Neuro-Oncol, 130, pp. 561-570, (2016)
  76. Khan N.R., Patel P.G., Sharpe J.P., Et al., Chemical venous thromboembolism prophylaxis in neurosurgical patients: An updated systematic review and meta-analysis, J Neurosurg, 129, pp. 906-915, (2018)